4th Annual Cardio Renal Connections Conference
January 28-30, 2021
Conference times are Central Standard Time (CST)
Registration also allows Course lectures to be available after the conference on-line through Sunday, March 28th.
CARDIO RENAL CONNECTIONS
Bridging Heart, Kidney and Metabolic Diseases
There are few who combine a career as physician, teacher, author and TED speaker, Dr. Abraham Verghese. Dr. Verghese is a critically acclaimed, best-selling author and a physician with an international reputation for his focus on healing. Dr. Verghese emphasizes humanity over technology. He is Professor and Vice Chair for the Theory and Practice of Medicine at the School of Medicine at Stanford University. In February 2014, he received a Heinz Award from Teresa Heinz and the Heinz Family Foundation and in 2016 National Humanities Medal from President Barack Obama.
Abraham Verghese, MD
Matthew R. Weir, MD
Dr. Weir is a Professor of Medicine and Director of the Division of Nephrology
at the University of Maryland School of Medicine. He has active NIH supported
grants from NIDDK, and NHLBI. Dr. Weir’s primary research interests include
cardiovascular disease in patients with chronic kidney disease, transplantation
effects on cardiovascular disease, hypertensive renal injury in African Americans.
Claudio Ronco, MD
Dr. Ronco serves as a Professor of Medicine and Director of the Department of
Nephrology and International Renal Research Institute at St. Bortolo Hospital,
Vicenza, Italy. He is a pioneer in many areas including peritoneal dialysis, critical
care nephrology, continuous renal replacement, cardiorenal syndromes and wearable dialysis
technology. Dr. Ronco’s contributions have been critical in revolutionizing the cardiorenal field.
Ralph DeFronzo, MD
Known as the developer of Metformin, Ralph DeFronzo is a Professor of Medicine and Chief of Diabetes in the Long School of Medicine at UT Health San Antonio, Texas. He is directly responsible for many of the advances achieved in diabetes over the last 50 years including SGLT2 inhibitors, the concept of insulin resistance and defining characteristics of Type 2 diabetes.
Clyde W. Yancy, MD, MSc
Dr. Yancy is Chief of Cardiology at Northwestern University, Feinberg School of Medicine, and Associate Director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. He holds the Magerstadt Endowed Professor of Medicine Chair and also serves as Professor of Medical Social Sciences. He concurrently serves as Vice Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine. personalized medicine, and health care disparities.
George Bakris, MD
Dr. Bakris is a Professor of Medicine and Director of the Comprehensive
Hypertension Center at University of Chicago. He is considered the world expert
in the diagnosis and reduction of high blood pressure particularly in complicated
and refractory cases. He also has special expertise in diabetes-related kidney
disease and slowing its progression.
WHAT HAPPENS HERE
WILL CHANGE HEALTHCARE
Lectures. Networking. Workshops. CE Credit.
SESSION LEADERS AND SPEAKERS
ESSENTIAL WORKSHOPS AND PANELS FOR MEDICAL PROFESSIONALS
DAYS OF WORLD-CLASS CONTENT
WHAT IS CARDIO RENAL CONNECTIONS ALL ABOUT?
Cardio Renal Connections is a unique meeting bringing together clinicians and scientists to explore the complex relationships between the heart and kidney. The interplay between the kidneys and the cardiovascular system is complex. The close relationship of renal function and cardiac function has given rise to the concept of cardio renal syndromes. This interplay extends beyond these syndromes and manifests itself in the form of hypertension, metabolic syndrome, and peripheral vascular disease. With the epidemic of obesity, diabetes, and aging of the United States population, physicians will continue to face a growing number of patients with renal and cardiovascular disease. This interprofessional CE program will serve to help foster education and discussion about the intersection of these two pathophysiologic systems.
High-Dose Spironolactone When Patients With Acute Decompensated Heart Failure Are Resistant to Loop Diuretics: A Pilot Study